Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros

Asunto principal
Tópicos
Tipo del documento
Intervalo de año
1.
PLoS One ; 17(4): e0267397, 2022.
Artículo en Inglés | MEDLINE | ID: covidwho-1808576

RESUMEN

At the time of the COVID-19 pandemic, providing access to data (properly optimised regarding personal data protection) plays a crucial role in providing the general public and media with up-to-date information. Open datasets also represent one of the means for evaluation of the pandemic on a global level. The primary aim of this paper is to describe the methodological and technical framework for publishing datasets describing characteristics related to the COVID-19 epidemic in the Czech Republic (epidemiology, hospital-based care, vaccination), including the use of these datasets in practice. Practical aspects and experience with data sharing are discussed. As a reaction to the epidemic situation, a new portal COVID-19: Current Situation in the Czech Republic (https://onemocneni-aktualne.mzcr.cz/covid-19) was developed and launched in March 2020 to provide a fully-fledged and trustworthy source of information for the public and media. The portal also contains a section for the publication of (i) public open datasets available for download in CSV and JSON formats and (ii) authorised-access-only section where the authorised persons can (through an online generated token) safely visualise or download regional datasets with aggregated data at the level of the individual municipalities and regions. The data are also provided to the local open data catalogue (covering only open data on healthcare, provided by the Ministry of Health) and to the National Catalogue of Open Data (covering all open data sets, provided by various authorities/publishers, and harversting all data from local catalogues). The datasets have been published in various authentication regimes and widely used by general public, scientists, public authorities and decision-makers. The total number of API calls since its launch in March 2020 to 15 December 2020 exceeded 13 million. The datasets have been adopted as an official and guaranteed source for outputs of third parties, including public authorities, non-governmental organisations, scientists and online news portals. Datasets currently published as open data meet the 3-star open data requirements, which makes them machine-readable and facilitates their further usage without restrictions. This is essential for making the data more easily understandable and usable for data consumers. In conjunction with the strategy of the MH in the field of data opening, additional datasets meeting the already implemented standards will be also released, both on COVID-19 related and unrelated topics.


Asunto(s)
COVID-19 , COVID-19/epidemiología , República Checa/epidemiología , Humanos , Difusión de la Información , Pandemias/prevención & control , SARS-CoV-2
2.
BMJ Open ; 11(2): e045442, 2021 02 23.
Artículo en Inglés | MEDLINE | ID: covidwho-1099776

RESUMEN

OBJECTIVES: COVID-19 might either be entirely asymptomatic or manifest itself with a large variability of disease severity. It is beneficial to identify early patients with a high risk of severe course. The aim of the analysis was to develop a prognostic model for the prediction of the severe course of acute respiratory infection. DESIGN: A population-based study. SETTING: Czech Republic. PARTICIPANTS: The first 7455 consecutive patients with COVID-19 who were identified by reverse transcription-PCR testing from 1 March 2020 to 17 May 2020. PRIMARY OUTCOME: Severe course of COVID-19. RESULT: Of a total 6.2% of patients developed a severe course of COVID-19. Age, male sex, chronic kidney disease, chronic obstructive pulmonary disease, recent history of cancer, chronic heart failure, acid-related disorders treated with proton-pump inhibitors and diabetes mellitus were found to be independent negative prognostic factors (Area under the ROC Curve (AUC) was 0.893). The results were visualised by risk heat maps, and we called this diagram a 'covidogram'. Acid-related disorders treated with proton-pump inhibitors might represent a negative prognostic factor. CONCLUSION: We developed a very simple prediction model called 'covidogram', which is based on elementary independent variables (age, male sex and the presence of several chronic diseases) and represents a tool that makes it possible to identify-with a high reliability-patients who are at risk of a severe course of COVID-19. Obtained results open clinically relevant question about the role of acid-related disorders treated by proton-pump inhibitors as predictor for severe course of COVID-19.


Asunto(s)
COVID-19 , Adulto , Anciano , Anciano de 80 o más Años , República Checa , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Investigación , SARS-CoV-2
3.
J Med Internet Res ; 2020.
Artículo | WHO COVID | ID: covidwho-268536

RESUMEN

BACKGROUND: The beginning of the COVID-19 epidemic dates back to December 31, 2019, when first cases were reported in the People's Republic of China. In the Czech Republic, the first three cases of infection with the novel coronavirus were confirmed on March 1, 2020. The joint effort of state authorities and researchers gave rise to a unique team, which combines methodical knowledge of real-world processes with the know-how needed for effective processing, analysis and online visualization of data. OBJECTIVE: Due to an urgent need for a tool which would make it possible to present important reports, and which would be based on valid data sources only, a team of government experts together with researchers focused on the design and development of a web application intended to provide a regularly updated overview of COVID-19 epidemiology in the Czech Republic to the general public. METHODS: The CRISP-DM (CRoss-Industry Standard Process for Data Mining) standardized methodology for knowledge mining from database structures was chosen for the complex solution of analytical processing and visualization of data, which provides validated information on the COVID-19 epidemic across the Czech Republic. Great emphasis was put on the understanding and a correct implementation of all six steps (business understanding, data understanding, data preparation, modelling, evaluation and deployment) needed in the process, including the infrastructure of a nationwide information system, the methodological setting of communication channels between all involved stakeholders, as well as data collection, processing, analysis, validation and visualization. RESULTS: The web-based overview of the current spread of COVID-19 in the Czech Republic has been developed as an online platform providing a set of outputs in the form of tables, graphs and maps intended for the general public. On March 12, 2020, the first version of the web portal, containing fourteen overviews divided into five topical sections, was released. The web portal's primary objective is to publish a well-arranged visualization and clear explanation of basic information consisting of the overall numbers of performed tests, confirmed cases of COVID-19, and COVID-19-related deaths together with the daily and cumulative overviews of COVID-19-positive persons, performed tests, location and country of infection of COVID-19-positive persons, hospitalizations of COVID-19 patients, and distribution of personal protective equipment. CONCLUSIONS: The online interactive overview of the current spread of COVID-19 in the Czech Republic was launched on March 11, 2020, and has immediately become the primary communication channel employed by the health care sector to present the current situation regarding the COVID-19 epidemic. This complex reporting of the coronavirus disease epidemic in the Czech Republic also shows an effective way how to interconnect knowledge held by various specialists, such as regional and national methodology experts, who report positive cases of the disease on a daily basis, with knowledge held by developers of central registries, analysts, developers of web applications and leadership in the health care sector. CLINICALTRIAL:

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA